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Editorial
In the dawn of the laboratory medicine era, we 
had a different view of quality. Back when we were 
pipetting tests by mouth, and we were constantly 
tinkering with the instrumentation, and the pa-
tient volumes were, by today’s standards, minis-
cule, we didn’t mind as much error. Error rates of 
1%, 5%, 10%, that wasn’t so bad.
In the last half century, so much has changed, not 
only in the laboratory but in the expectations of 
quality management. What was once acceptable 
in terms of defect rates has now become unsus-
tainable for today’s automated high volume oper-
ations. When many laboratories are routinely 
reaching millions of reportables per year (some 
even per month!), even a 1% error rate is ruinous to 
the laboratory’s ability to produce reliable turn-
around times and accurate results.
All around us, the laboratory has made a quantum 
leap forward in output and effectiveness. Instru-
ments have been engineered to better precision, 
as automation has eliminated many error-prone 
processes, and as informatics has made communi-
cation of massive numbers of results possible. 
Without all of these improvements, laboratories 
would not have been able to keep up with the 
clinical demand.
But our expectation of quality has not evolved 
commensurately. Many laboratories retain the old 
mindset of 1%, 5%, 10% error rates as acceptable. 
They focus on pre-analytical and post-analytical 
processes, leaving the analytical quality of their 
tests unexamined, unverified, and unimproved. 
Laboratories that ignore their analytical quality do 
so at their own peril, generating the wrong results 
faster and more cheaply than ever. As they trans-
form laboratories into number factories, they 
threaten to turn themselves into mere commodi-
ties, interchangeable cogs. The future for a labora-
tory that doesn’t focus on quality is not only con-
solidation, but possibly extinction itself. If we don’t 
value quality, don’t prove quality, don’t rigorously 
insist on quality in our tests, we are the just the lat-
est cobblers, saddle-markers, type-writer repair-
men, and apothecaries to see our profession 
erased by technological change.
Six Sigma and analytical Sigma metrics provide a 
solution to our challenges. Not only through Six 
Sigma can we identify when our methods are ac-
tually appropriate for clinical care, it can help 
change how much quality control (QC) we have to 
do, guide our risk management efforts, even make 
changes to the operational expenditures. This spe-
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cial issue of Biochemia Medica is a small sampling 
of how analytical Sigma metrics are being applied 
around the world.
Six Sigma has not been in the laboratory for very 
long – the first study that benchmarked laboratory 
quality on the Six Sigma scale came out in 2001, by 
David Nevelainen (1). So with less than two dec-
ades of application, it is a relatively new field, one 
that is not without its controversy, challenges and 
debates. But since 2001, a suite of tools have been 
developed to allow laboratories to harness the 
power of Six Sigma to assess method quality, opti-
mize QC procedures, change the number of rules 
and number of controls being run, and most re-
cently, even change the frequency of QC. Virtually 
all the questions we can ask about how and when 
to run QC can now be answered by the analytical 
Sigma metrics, and we provide a review of these 
techniques and developments in one of the cor-
nerstone articles in this issue. Xuehui Mao et al. 
show the application of Sigma metrics to assessing 
the quality of an instrument in a laboratory, the 
basic implementation that every laboratory can 
consider (2). Yong Xia et al. take the application 
one step further, incorporating Sigma metrics into 
the traditional risk assessments that connect test 
results to patient care (3). Cao and Qin show how 
analytical Sigma metrics can be used to evaluate 
whether or not third-party reagents are fit for pur-
pose, a key question in much of the developing 
world – where there is strong temptation to use a 
cheaper local reagent rather than the original 
manufacturer’s reagent;  the assumption that rea-
gents are interchangeable is too often unexam-
ined (4). At the other end of the testing lifecycle, 
Petrides and Schneider show how diagnostic man-
ufacturers are incorporating Sigma metrics into 
the earliest stages of assay design (5). 
Analytical Sigma metrics did not emerge out of a 
vacuum, they were built on a foundation of work 
completed over previous decades in critical sys-
tematic error, allowable analytical total error, and 
even the earliest equations that combined impre-
cision and bias into the global standard of analyti-
cal total error (6). There are debates and controver-
sies that have raged for decades about these foun-
dations and mathematical models (7-9). Hassan 
Bayat provides the most technical paper in this is-
sue, delving into the details of the analytical Sigma 
metric to reveal what we can calculate and what 
we may actually observe (10). Wyzte Oosterhuis 
details an alternate Sigma metric approach that 
avoids possible flaws in total allowable errors built 
from data on biological variation; even as we see 
our analytical goals tighten, Oosterhuis and 
Coskun note that we may still be allowing "too 
much error" to exist in our methods (11). They be-
lieve that while we are heading down the right 
road, we’re using the wrong map (model). It may 
be that both our maps are practically the same, 
and the differences are only of interest to the sea-
soned cartographer, not the casual traveler.
Another of the largest and most obvious challeng-
es of Six Sigma is the selection of the appropriate 
performance specification. How good does a test 
need to be? As anyone who looks are Clinical Lab-
oratory Improvement Amendments  (CLIA), The 
College of American Pathologists (CAP), Reference 
Institute for Bioanalytics (Rilibak), and The Royal 
College of Pathologists of Australasia external 
quality assessment goals can tell you, the world 
has not reached a consensus. In Germany, you may 
have a very large interlaboratory comparison goal 
for calcium, while those labs in Australia have a 
much tighter goal, and those trying to achieve a 
biologically derived goal might find the challenge 
still harder. There is no standardization of allowa-
ble total error performance specifications for labo-
ratory tests around the world. As long as external 
quality assurance (EQA) programs are competing 
against each other for business, it’s unlikely that 
they will harmonize or standardize (wider goals 
provide a financial advantage, making for happier 
customers). If we can’t agree on a standard perfor-
mance specification, it makes our calculated ana-
lytical Sigma metrics incomparable. Guo et al. 
show the differences in Sigma metrics that can be 
calculated when Chinese national performance 
specifications are used vs the United States CLIA/
CAP goals (12). We showed how a standardization 
protocol in Egypt is being introduced to encour-
age all laboratories to use the same quality goals 
for their Sigma metrics benchmarks (13). Finally, 
Varela and Pacheco introduce a new evaluation 
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matrix that allows laboratories to assess which 
performance specification may be most appropri-
ate for use (14).
The contribution to the advancement of QC prac-
tices and efficient operation of the laboratory 
through Six Sigma cannot be ignored. Laborato-
ries, even as they acknowledge the debates and 
challenges that will continue to feature in the use 
of Six Sigma, need to begin implementing Sigma 
metrics to optimize their practices. Future de-
mands to “do more with less” – our constant man-
tra – can only be realized through adoption of ad-
vanced quality techniques such as Six Sigma.   
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